iPS Cells & Regenerative Medicine– category –
-
Vertex’s Zimislecel Cell Therapy Achieves Insulin Independence in 10 of 12 Type 1 Diabetes Patients
Breakthrough T1D Australia Overview Vertex Pharmaceuticals announced highly promising results from its FORWARD-101 trial of Zimislecel (formerly VX-880), an iPSC-derived cell therapy for Type 1 Diabetes (T1D). Ten of 12 participants achi... -
iPSC Clinical Trials Deliver Breakthroughs: Parkinson’s, Heart Failure, Cancer Immunotherapies Show Promising Results
Americord Registry USA Overview Induced pluripotent stem cell (iPSC) research is rapidly transforming medicine, with multiple clinical trials reporting significant progress across diverse disease areas. A Kyoto University Hospital trial ... -
FUJIFILM Cellular Dynamics Quadruples iPSC Manufacturing Capacity with New Madison Facility
FUJIFILM Cellular Dynamics USA Overview FUJIFILM Cellular Dynamics (FCDI) has inaugurated a new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin. This strategic expansion quadruples FCDI's capacity for p... -
Laser-Precision 3D Bioprinting: Ushering in a New Era for Organoid and Tissue Engineering
技術情報発信（素材技術を未来へ） Japan Overview Advances in 3D bioprinting are enabling the creation of highly complex organoid and tissue models, transcending the limitations of random self-assembly. Key innovations, such as Poietis' NG... -
iPS Cells & Regenerative Medicine Weekly Report May 18, 2026
📄 Weekly Report May 18, 2026 (PDF) — Download Weekly Report May 18, 2026 (PDF) — DownloadDownload 🎙 Podcast May 18, 2026 (MP3) — Play & Download iPS_RegenerativeMedicineEnglishPodcast_20260518_sample.mp3Download -
XellSmart Initiates Phase II Trial for iPSC-Based Parkinson’s Therapy Following Encouraging Phase I Results
The Regen Report USA Overview XellSmart has advanced its iPSC-derived cellular therapy for Parkinson's disease into Phase II clinical trials, driven by positive safety and preliminary efficacy data from its Phase I study. This critical p... -
NIH-Funded Research Achieves Breakthrough in Shrinking CRISPR Systems for Enhanced In Vivo Precision Delivery
European AIDS Treatment Group (EATG) News USA Overview NIH-funded research has successfully developed miniaturized CRISPR-Cas gene editing systems, overcoming a significant hurdle in in vivo delivery for traditional larger systems. This ... -
Cell-Easy Launches Large-Scale iPSC-Derived Beta Cell Program to Address Manufacturing Bottlenecks for Diabetes Therapy
BioInformant USA Overview Cell-Easy has initiated a new program focused on scaling up the manufacturing of iPSC-derived beta cells, addressing a critical bottleneck for diabetes therapies. This initiative aims to establish a stable, high... -
Americord Registry Spotlights Latest Breakthroughs in iPSC Clinical Trials Across Diverse Disease Areas
Americord Registry USA Overview Americord Registry has released a comprehensive report detailing the latest advancements in iPSC clinical trials, highlighting expanding applications in neurological and ophthalmic conditions. The report i... -
Locus Cell Establishes Large-Scale Manufacturing Process for Human Umbilical Cord Mesenchymal Stem Cells Using CellFiber® Technology
PR Times Japan Overview Locus Cell Inc., in collaboration with CellFiber Inc., has announced the successful establishment of a large-scale, high-efficiency manufacturing process for human umbilical cord-derived mesenchymal stem cells (UC...
